Page 94 - Read Online

Page 14 of 15 Della Corte et al. Hepatoma Res 2022;8:5 https://dx.doi.org/10.20517/2394-5079.2021.103

2014;60:1268-89. DOI PubMed
56. Xu C, Li L, Xu W, et al. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic
cholangiocarcinoma: intermediate-term results. Int J Hyperthermia 2019;36:351-8. DOI PubMed
57. Carrafiello G, Laganà D, Cotta E, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.
Cardiovasc Intervent Radiol 2010;33:835-9. DOI PubMed
58. Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc
Intervent Radiol 2013;36:505-11. DOI PubMed PMC
59. Yousaf A, Kim JU, Eliahoo J, Taylor-Robinson SD, Khan SA. Ablative therapy for unresectable intrahepatic cholangiocarcinoma: a
systematic review and meta-analysis. J Clin Exp Hepatol 2019;9:740-8. DOI PubMed PMC
60. Sweeney J, Parikh N, El-Haddad G, Kis B. Ablation of intrahepatic cholangiocarcinoma. Semin Intervent Radiol 2019;36:298-302.
DOI PubMed PMC
61. Yu MA, Liang P, Yu XL, et al. Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma. Eur
J Radiol 2011;80:548-52. DOI PubMed
62. Ni JY, An C, Zhang TQ, Huang ZM, Jiang XY, Huang JH. Predictive value of the albumin-bilirubin grade on long-term outcomes of
CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperthermia 2019;36:328-36. DOI PubMed
63. Yu MA, Liang P, Yu XL, et al. Liver abscess as a complication of microwave ablation for liver metastatic cholangiocarcinoma after
bilioenteric anastomosis. Int J Hyperthermia 2011;27:503-9. DOI PubMed
64. Lucatelli P, Burrel M, Guiu B, de Rubeis G, van Delden O, Helmberger T. CIRSE standards of practice on hepatic transarterial
chemoembolisation. Cardiovasc Intervent Radiol 2021;44:1851-67. DOI PubMed
65. Kiefer MV, Albert M, McNally M, et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin,
mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer 2011;117:1498-505. DOI PubMed
66. Shen WF, Zhong W, Liu Q, Sui CJ, Huang YQ, Yang JM. Adjuvant transcatheter arterial chemoembolization for intrahepatic
cholangiocarcinoma after curative surgery: retrospective control study. World J Surg 2011;35:2083-91. DOI PubMed
67. Odisio BC, Richter M, Aloia TA, et al. Use of prophylactic antibiotics to prevent abscess formation following hepatic ablation in
patients with prior enterobiliary manipulation. J Gastrointest Surg 2016;20:1428-34. DOI PubMed PMC
68. Ierardi AM, Angileri SA, Patella F, et al. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma. Med
Oncol 2017;34:11. DOI PubMed
69. Cohen MJ, Bloom AI, Barak O, et al. Trans-arterial chemo-embolization is safe and effective for very elderly patients with
hepatocellular carcinoma. World J Gastroenterol 2013;19:2521-8. DOI PubMed PMC
70. Aliberti C, Benea G, Tilli M, Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-
release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 2008;31:883-8. DOI PubMed
71. Venturini M, Sallemi C, Agostini G, et al. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs
doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study. Br J Radiol
2016;89:20160247. DOI PubMed PMC
72. Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R. Radioembolization for the treatment of liver tumors general principles. Am J
Clin Oncol 2012;35:91-9. DOI PubMed
73. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere
brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys
2007;68:13-23. DOI PubMed
74. Buettner S, Braat AJAT, Margonis GA, et al. Yttrium-90 radioembolization in intrahepatic cholangiocarcinoma: a multicenter
retrospective analysis. J Vasc Interv Radiol 2020;31:1035-43.e2. DOI PubMed
75. Al-Adra DP, Gill RS, Axford SJ, Shi X, Kneteman N, Liau SS. Treatment of unresectable intrahepatic cholangiocarcinoma with
yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol 2015;41:120-7. DOI PubMed PMC
76. Ibrahim SM, Mulcahy MF, Lewandowski RJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres:
results from a pilot study. Cancer 2008;113:2119-28. DOI PubMed
77. Hoffmann RT, Paprottka PM, Schön A, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable
intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol 2012;35:105-16. DOI
PubMed
78. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a
preliminary assessment of this novel treatment option. Ann Surg Oncol 2010;17:484-91. DOI PubMed
79. Cucchetti A, Cappelli A, Mosconi C, et al. Improving patient selection for selective internal radiation therapy of intra-hepatic
cholangiocarcinoma: a meta-regression study. Liver Int 2017;37:1056-64. DOI PubMed
80. Gangi A, Shah J, Hatfield N, et al. Intrahepatic cholangiocarcinoma treated with transarterial Yttrium-90 glass microsphere
radioembolization: results of a single institution retrospective study. J Vasc Interv Radiol 2018;29:1101-8. DOI PubMed PMC
81. Helmberger T, Golfieri R, Pech M, et al; On behalf of the CIRT Steering Committee; On behalf of the CIRT Principal Investigators.
Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre
observational study CIRSE registry for SIR-spheres therapy (CIRT). Cardiovasc Intervent Radiol 2021;44:21-35. DOI PubMed
PMC
82. Riaz A, Lewandowski RJ, Kulik LM, et al. Complications following radioembolization with yttrium-90 microspheres: a
comprehensive literature review. J Vasc Interv Radiol 2009;20:1121-30; quiz 1131. DOI PubMed
83. Riby D, Mazzotta AD, Bergeat D, et al. Downstaging with radioembolization or chemotherapy for initially unresectable intrahepatic